Author

Thomas Seyfried

Professor of Biology, Boston Cllege - Cited by 17,501 - ketogenic diets

Biography

 Dr. Seyfried has been a featured speaker at numerous scientific symposia and conferences relating to cancer, including the 2nd Annual Ancestral Health Symposium, 2012; The Educational Session Lecture, American Association Cancer Research, 2013, and the Institute for Human & Machine Cognition (IHMC), 2015.
Title
Cited by
Year
Therapeutic benefit of combining calorie-restricted ketogenic diet and glutamine targeting in late-stage experimental glioblastoma
P Mukherjee, ZM Augur, M Li, C Hill, B Greenwood, MA Domin, ...Communications Biology 2 (1), 200, 2019201
88
2019
Sex-related abnormalities in substantia nigra lipids in Parkinson’s disease
TN Seyfried, H Choi, A Chevalier, D Hogan, Z Akgoc, JS SchneiderASN neuro 10, 1759091418781889, 2018201
86
2018
Press-pulse: a novel therapeutic strategy for the metabolic management of cancer
TN Seyfried, G Yu, JC Maroon, DP D’AgostinoNutrition & metabolism 14, 1-17, 2017201
83
2017
82
2018
Management of glioblastoma multiforme in a patient treated with ketogenic metabolic therapy and modified standard of care: a 24-month follow-up
AMA Elsakka, MA Bary, E Abdelzaher, M Elnaggar, M Kalamian, ...Frontiers in nutrition 5, 20, 2018201
81
2018
Effects of Ketogenic metabolic therapy on patients with breast cancer: A randomized controlled clinical trial
A Khodabakhshi, ME Akbari, HR Mirzaei, TN Seyfried, M Kalamian, ...Clinical Nutrition 40 (3), 751-758, 2021202
66
2021
On the origin of ATP synthesis in cancer
TN Seyfried, G Arismendi-Morillo, P Mukherjee, C ChinopoulosIscience 23 (11), 2020202
50
2020
Environmental stimuli shape microglial plasticity in glioma
S Garofalo, A Porzia, F Mainiero, S Di Angelantonio, B Cortese, B Basilico, ...Elife 6, e33415, 2017201
45
2017
Provocative question: should ketogenic metabolic therapy become the standard of care for glioblastoma?
TN Seyfried, L Shelton, G Arismendi-Morillo, M Kalamian, A Elsakka, ...Neurochemical research 44, 2392-24, 2019201
40
2019
Consideration of ketogenic metabolic therapy as a complementary or alternative approach for managing breast cancer
TN Seyfried, P Mukherjee, MS Iyikesici, A Slocum, M Kalamian, ...Frontiers in Nutrition, 21, 2020202
37
2020
Personalized nutrition in disrupting cancer—Proceedings from the 2017 American College of Nutrition Annual Meeting
TC Wallace, S Bultman, C D’Adamo, CR Daniel, J Debelius, E Ho, ...Journal of the American College of Nutrition 38 (1), 1-14, 2019201
27
2019
Mitochondrial correction: a new therapeutic paradigm for cancer and degenerative diseases
MJ Gonzalez, T Seyfried, GL Nicolson, BJ Barclay, J Matta, A Vasquez, ...J. Orthomol. Med 33 (4), 2018201
21
2018
Mycoplasma infection and hypoxia initiate succinate accumulation and release in the VM-M3 cancer cells
RE Flores, AK Brown, L Taus, J Khoury, F Glover, K Kami, ...Biochimica et Biophysica Acta (BBA)-Bioenergetics 1859 (9), 975-983, 2018201
19
2018
Caprylic (Octanoic) Acid as a potential fatty acid chemotherapeutic for glioblastoma
MA Altinoz, A Ozpinar, TN SeyfriedProstaglandins, Leukotrienes and Essential Fatty Acids 159, 102142, 2020202
16
2020
Ketogenic metabolic therapy, without chemo or radiation, for the long-term management of IDH1-mutant glioblastoma: an 80-month follow-up case report
TN Seyfried, AG Shivane, M Kalamian, JC Maroon, P Mukherjee, ...Frontiers in Nutrition, 281, 2021202
14
2021
Metabolic therapy and bioenergetic analysis: The missing piece of the puzzle
T Duraj, J Carrión-Navarro, TN Seyfried, N García-Romero, ...Molecular Metabolism 54, 101389, 2021202
14
2021
Gene expression in the epileptic (EL) mouse hippocampus
TS Lee, AY Li, A Rapuano, J Mantis, T Eid, TN Seyfried, NC de LanerolleNeurobiology of Disease 147, 105152, 2021202
13
2021
Chemical mutagenesis of a GPCR ligand: Detoxifying “inflammo-attraction” to direct therapeutic stem cell migration
JP Lee, R Zhang, M Yan, S Duggineni, DR Wakeman, WL Niles, Y Feng, ...Proceedings of the National Academy of Sciences 7 (49), 377-388, 2020202
11
2020